Trial site
Saiseikai Kumamoto Hospital
- 11running trials
- 6closed trials
The trials here
What the 17 trials at this site are about, from their registry records.
- Conditions
- Lung cancer7 trials
- Atrial fibrillation2 trials
- Migraine2 trials
- COPD1 trial
- Coronary artery disease1 trial
- Heart failure1 trial
- Hypertrophic cardiomyopathy1 trial
- Phase
- Phase 313 trials
- Status
- Active, not recruiting9 trials
- Completed6 trials
- Recruiting2 trials
- Lead sponsor
- Daiichi Sankyo3 trials
- Janssen Research & Development, LLC2 trials
- Pfizer2 trials
- Abbott Medical Devices1 trial
- Bayer1 trial
- and 8 more
Running trials
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
REZILIENT3 (REsearching ZIpaLertinib In Egfr Non-small Cell Lung Cancer Tumors)
Active, not recruiting
Active, not recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer2 recruiting
Closed trials
Completed
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
Completed
Efficacy and Safety Study of Rimegepant for Migraine Prevention in Japanese Subjects (Japan Only)
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026